Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why 55% of Clinical Trials Fail – The Truth About Drug Development

43:51
 
Share
 

Manage episode 466325535 series 3446111
Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at George Washington University School of Medicine and Health Sciences.

Rob shares insider knowledge on why over 55% of clinical trials fail, the high costs of drug development, and how misaligned priorities between researchers, regulators, and sponsors can derail promising treatments. He also reveals how streamlining clinical trials, improving patient recruitment, and leveraging AI and real-world data can help bring life-saving drugs to market faster.

If you're curious about the future of medicine, drug approvals, or how rare disease treatments are developed, this is an episode you don’t want to miss!

Chapters:

00:00 Introduction – Why Clinical Trials Matter
02:59 The Real Reason Many Clinical Trials Fail
08:18 Where the Industry Wastes the Most Money
15:28 How Misalignment in Drug Development Happens
27:00 The Future of AI in Clinical Trials
34:19 How to Fix Broken Clinical Trials
41:03 Final Thoughts & Key Takeaways

🔗 Links Mentioned:
🌐 Visit Uncommon Cures
📌 Follow Rob Freishtat on LinkedIn

More from Life Sciences 360:
🎥 Youtube:/ @lifesciences360

For transcripts, check out the podcast website - www.lifesciencespod.com

  continue reading

Chapters

1. Introduction – Why Clinical Trials Matter (00:00:00)

2. The Real Reason Many Clinical Trials Fail (00:02:59)

3. Where the Industry Wastes the Most Money (00:08:18)

4. How Misalignment in Drug Development Happens (00:15:28)

5. The Future of AI in Clinical Trials (00:27:00)

6. How to Fix Broken Clinical Trials (00:34:19)

7. Final Thoughts & Key Takeaways (00:41:03)

86 episodes

Artwork
iconShare
 
Manage episode 466325535 series 3446111
Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at George Washington University School of Medicine and Health Sciences.

Rob shares insider knowledge on why over 55% of clinical trials fail, the high costs of drug development, and how misaligned priorities between researchers, regulators, and sponsors can derail promising treatments. He also reveals how streamlining clinical trials, improving patient recruitment, and leveraging AI and real-world data can help bring life-saving drugs to market faster.

If you're curious about the future of medicine, drug approvals, or how rare disease treatments are developed, this is an episode you don’t want to miss!

Chapters:

00:00 Introduction – Why Clinical Trials Matter
02:59 The Real Reason Many Clinical Trials Fail
08:18 Where the Industry Wastes the Most Money
15:28 How Misalignment in Drug Development Happens
27:00 The Future of AI in Clinical Trials
34:19 How to Fix Broken Clinical Trials
41:03 Final Thoughts & Key Takeaways

🔗 Links Mentioned:
🌐 Visit Uncommon Cures
📌 Follow Rob Freishtat on LinkedIn

More from Life Sciences 360:
🎥 Youtube:/ @lifesciences360

For transcripts, check out the podcast website - www.lifesciencespod.com

  continue reading

Chapters

1. Introduction – Why Clinical Trials Matter (00:00:00)

2. The Real Reason Many Clinical Trials Fail (00:02:59)

3. Where the Industry Wastes the Most Money (00:08:18)

4. How Misalignment in Drug Development Happens (00:15:28)

5. The Future of AI in Clinical Trials (00:27:00)

6. How to Fix Broken Clinical Trials (00:34:19)

7. Final Thoughts & Key Takeaways (00:41:03)

86 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play